News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Inside Information / News release on accounts, results
Aliko Scientific (Ikonisys SA) reports 52.6% increase in total revenue to €1.64 million and 32.9% improvement in EBITDA for 2025. Developments include US patent for ACTA, launch of Urine24, and agreement with Menarini Diagnostics -
-
-
-